Citigroup Inc Sesen Bio, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.49 - $0.61 $1,204 - $1,499	-2,459 Reduced 94.58%	141 $0
Q3 2022 Nov 10, 2022	SELL	$0.0 - $0.93 $0 - $2,445	-2,630 Reduced 50.29%	2,600 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.89 $2,753 - $6,448	-7,246 Reduced 58.08%	5,230 $4,000
Q1 2022 May 12, 2022	SELL	$0.58 - $0.86 $27,264 - $40,426	-47,007 Reduced 79.03%	12,476 $8,000
Q4 2021 Feb 10, 2022	BUY	$0.73 - $1.28 $22,938 - $40,220	31,422 Added 111.98%	59,483 $48,000
Q3 2021 Nov 10, 2021	BUY	$0.77 - $4.91 $21,606 - $137,779	28,061 New	28,061 $22,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.